Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-29T13:30:05.607Z Has data issue: false hasContentIssue false
  • English
  • Français

Lost in Anonymization — A Data Anonymization Reference Classification Merging Legal and Technical Considerations

Published online by Cambridge University Press:  01 January 2021

Kerstin N. Vokinger ,
Daniel J. Stekhoven  and
Michael Krauthammer
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Health Policy Portal
Information
Journal of Law, Medicine & Ethics , Volume 48 , Issue 1: LawSeq: Building a Sound Legal Foundation for Translating Genomics into Clinical Application , Spring 2020 , pp. 228 - 231
Copyright
Copyright © American Society of Law, Medicine and Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cassel, C. and Bindman, A., “Risk, Benefit, and Fairness in a Big Data World,” JAMA 322, no. 2 (2019): 105.CrossRefGoogle Scholar
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, “Pan-Cancer Analysis of Whole Genomes,” Nature 578, no. 7793 (2020): 82–93; See also <https://clinicalgenome.org/> (last visited February 27, 2020); The Global Alliance for Genomics and Health, A Federated Ecosystem for Sharing Genomic, Clinical Data,” Science 352, no. 6291 (2016): 1278-80.+(last+visited+February+27,+2020);+The+Global+Alliance+for+Genomics+and+Health,+A+Federated+Ecosystem+for+Sharing+Genomic,+Clinical+Data,”+Science+352,+no.+6291+(2016):+1278-80.>Google Scholar
See supra note 1; Price, W. N. and Cohen, I. G., “Privacy in the Age of Medical Big Data,” Nature Medicine 25, no. 1 (2019): 37–43.CrossRefGoogle Scholar
See <https://ec.europa.eu/info/law/law-topic/data-protection/reform/what-does-general-data-protection-regulation-gdpr-govern_en> (last visited February 27, 2020); Art. 4 GDPR, available at <https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1528874672298&uri=CELEX:32016R0679> (last visited February 27, 2020).+(last+visited+February+27,+2020);+Art.+4+GDPR,+available+at++(last+visited+February+27,+2020).>Google Scholar
Global Alliance, supra note 2.Google Scholar
Albrecht, J.P., “How the GDPR Will Change the World,” European Data Protection Law Review 2, no. 3 (2016): 287–289.CrossRefGoogle Scholar
Rosenthal, D. and Jöhri, Y., Hand-kommentar zum Datenschutzgesetz (Zurich/Basel/Geneva: Schulthess; 2008).Google Scholar
Vokinger, K. and Muehlematter, U., “Re-Identifikation von Gerichtsurteilen durch «Linkage» von Daten (Banken). Eine Empirische Analyse anhand von Bundesgerichtsbeschwerden Gegen (Preisfestsetzungs-)Verfügungen von Arzneimitteln,” Jusletter (2019).Google Scholar
Id.Google Scholar
Price and Cohen, supra note 3.Google Scholar
Sweeney, L., Yoo, J. S., Perovich, L., Boronow, K. E., Brown, P., and Brody, J. G., “Re-identification Risks in HIPAA Safe Harbor Data: A Study of Data from One Environmental Health Study,” Technology Science (2017), available at <https://techscience.org/a/2017082801> (last visited March 13, 2020); Janmey, V. and Elkin, P. L., “Re-Identification Risk in HIPAA De-Identified Datasets: The MVA Attack,” AMIA Annual Symposium Proceedings (2018): 1329-1337.+(last+visited+March+13,+2020);+Janmey,+V.+and+Elkin,+P.+L.,+“Re-Identification+Risk+in+HIPAA+De-Identified+Datasets:+The+MVA+Attack,”+AMIA+Annual+Symposium+Proceedings+(2018):+1329-1337.>Google Scholar
See <https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html#determinations> (last visited February 27, 2020).+(last+visited+February+27,+2020).>Google Scholar
Id.Google Scholar
On behalf of the ACMG Secondary Findings Maintenance Working Group, Kalia, S.S., Adelman, K. et al., “Recommendations for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing: 2016 update (ACMG SF v2.0): A Policy Statement of the American College of Medical Genetics and Genomics,” Genetic Medicine 19, no. 2 (2017): 249–55.CrossRefGoogle Scholar
Atreya, R. V., Smith, J. C., McCoy, A. B., Malin, B., and Miller, R. A., “Reducing Patient Re-Identification Risk for Laboratory Results within Research Datasets,” Journal of the American Medical Informatics Association 20, no. 1 (2013): 95–101.CrossRefGoogle Scholar
Id.Google Scholar